In 2013, advances in noninvasive imaging methods pushed traditional boundaries in the detection, diagnosis, and functional assessment of coronary artery disease, atherosclerotic plaque, and myocardial function. We highlight five important studies that demonstrate how these developments are allowing medicine to become increasingly evidence-based and personalized.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Schmidt, M. et al. F-18-FDG uptake is a reliable predictor of functional recovery of akinetic but viable infarct regions as defined by magnetic resonance imaging before and after revascularisation. Magn. Reson. Imaging 22, 229–236 (2004).
Shah, D. J. et al. Prevalence of regional myocardial thinning and relationship with myocardial scarring in patients with coronary artery disease. JAMA 309, 909–918 (2013).
Meijboom, W. B., Van Mieghem, C. A. & van Pelt, N. Comprehensive assessment of coronary artery stenoses: computed tomography coronary angiography versus conventional coronary angiography and correlation with fractional flow reserve in patients with stable angina. J. Am. Coll. Cardiol. 52, 636–643 (2008).
Nakazato, R. et al. Noninvasive fractional flow reserve derived from computed tomography angiography for lesions of intermediate stenosis severity: results from the DeFACTO study. Circ. Cadiovasc. Imaging 6, 881–889 (2013).
Plein, S. et al. High spatial resolution myocardial perfusion cardiac magnetic resonance for the detection of coronary artery disease. Eur. Heart J. 29, 2148–2155 (2008).
Schwitter, J. et al. MR-IMPACT II: magnetic resonance imaging for myocardial perfusion assessment in coronary artery disease trial: perfusion cardiac magnetic resonance vs single photon emission compute tomography for the detection of coronary artery disease: a comparative multicentre, multivendor trial. Eur. Heart J. 34, 775–781 (2013).
Mulrooney, D. A. et al. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the childhood cancer survivor study cohort. BMJ 339, b4606 (2009).
Ylanen, K. et al. Cardiac magnetic resonance imaging in the evaluation of the late effects of anthracyclines among long term survivors of childhood cancer. J. Am. Coll. Cardiol. 61, 1539–1547 (2013).
Dweck, M. R. et al. Coronary arterial 18F-fluoride uptake: a novel marker of plaque biology. J. Am. Coll. Cardiol. 59, 1539–1548 (2012).
Joshi, N. V. et al. 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial. Lancet http://dx.doi.org/10.1016/S0140-6736(13)61754-7.
Acknowledgements
The views and opinions of the authors do not necessarily state or reflect those of the US Government, and they may not be used for advertising or product endorsement purposes.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Pattanayak, P., Bluemke, D. New era of evidence-based medicine with noninvasive imaging. Nat Rev Cardiol 11, 74–76 (2014). https://doi.org/10.1038/nrcardio.2013.215
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrcardio.2013.215
